爪爪关怀:犬辅助干预对ICU患者及家属焦虑的影响:单中心单臂研究
本研究为前瞻性、单中心、单臂、非随机、受试者内设计,纳入三级医院ICU的成人(≥16岁)患者及其家属,评估个体化犬辅助干预(治疗犬,每次至少15分钟)对焦虑的影响。共招募141名参与者(70例患者和71名家属),患者中位年龄63(IQR 49-71)岁,家属51(IQR 36-61)岁。主要结果:患者VAS-A焦虑评分中位数从5(IQR 1-7)降至0(IQR 0-4,p<0.001),家属从6(IQR 5-8)降至3(IQR 1-5,p<0.001);56/70(62%)患者和63/68(93%)家属VAS-A评分降低≥2分。患者疼痛评分中位数也降低(0[IQR 0-5] vs 0[IQR 0-2],p<0.001),心率、呼吸频率和收缩压无统计学显著变化,未报告犬咬伤、抓伤或其他不良事件。作者认为CAI可即刻减轻ICU患者及家属的焦虑症状,可能作为疼痛管理的辅助治疗,需进一步研究其对长期心理结局的影响。
要点
- ICU成人患者(≥16岁)及其家属接受至少15分钟个体化治疗犬辅助干预后,患者VAS-A焦虑评分中位数从5(IQR 1-7)降至0(IQR 0-4),p<0.001。
- 家属VAS-A焦虑评分中位数从6(IQR 5-8)降至3(IQR 1-5),p<0.001。
- 56/70(62%)患者和63/68(93%)家属VAS-A评分降低≥2分。
- 患者疼痛评分中位数干预后降低(0[IQR 0-5] vs 0[IQR 0-2],p<0.001),心率、呼吸频率和收缩压无统计学显著变化。
- 未报告犬咬伤、抓伤或其他不良事件;作者认为CAI可即刻减轻焦虑,可能作为疼痛管理的辅助治疗,需进一步研究长期心理结局。
适用人群与场景
- 三级医院ICU的成人(≥16岁)患者及其家属。
处置流程与药物剂量
- 个体化犬辅助干预(治疗犬)每次至少15分钟。
研究设计与关键结果
- 研究设计为前瞻性、单中心、单臂、非随机、受试者内研究,共招募141名参与者(70例患者和71名家属)。
- 患者中位年龄63(IQR 49-71)岁,家属中位年龄51(IQR 36-61)岁。
- 患者VAS-A焦虑评分中位数从5(IQR 1-7)降至0(IQR 0-4),p<0.001;家属从6(IQR 5-8)降至3(IQR 1-5),p<0.001。
- 56/70(62%)患者和63/68(93%)家属VAS-A评分降低≥2分。
- 患者疼痛评分中位数干预后降低(0[IQR 0-5] vs 0[IQR 0-2],p<0.001)。
- 患者心率、呼吸频率和收缩压无统计学显著变化;未报告犬咬伤、抓伤或其他不良事件。
证据类型、等级与局限
- 证据类型:前瞻性、单中心、单臂、非随机、受试者内研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为CAI可即刻减轻ICU患者及家属的焦虑症状,未观察到不良事件,可能作为ICU患者疼痛管理的辅助治疗。
- 作者建议进一步研究应探索对ICU患者及家属长期心理结局的影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the effect of canine-assisted intervention (CAI) on anxiety symptoms among intensive care patients and their family members.
DESIGN: Prospective, single-center, single-arm, nonrandomized, within-subject study design.
SETTING: Tertiary hospital ICU.
PATIENTS/SUBJECTS: Adult (≥ 16 yr) ICU patients and their family members.
INTERVENTIONS: Individual CAI (therapy dog) sessions, lasting at least 15 minutes.
MEASUREMENTS AND MAIN RESULTS: Primary outcome: change in Visual Analog Scale for Anxiety (VAS-A) among patients and family members; secondary outcomes (patient cohort): change in: 1) Numeric Pain Rating Scale, 2) physiologic vital signs, and 3) intervention-related adverse events. A total of 141 participants (70 patients and 71 family members) were recruited. The median (interquartile range [IQR]) age (yr) was 63 (49-71) for patients, and 51 (36-61) for family members. There was a significant reduction in anxiety scores after the intervention, with median (IQR) VAS-A scores changing from 5 (1-7) to 0 (0-4 [p < 0.001]) for the patient cohort and from 6 (5-8) to 3 (1-5 [p < 0.001]) for the family cohort. Majority of patients (56/70 [62%]) and family members (63/68 [93%]) demonstrated a greater than or equal to 2-point reduction in VAS-A scores. In terms of pain, median (IQR) scores among the patient cohort were also lower post-intervention (0 [0-5] vs. 0 [0-2]; p < 0.001). There were no statistically significant changes in physiologic vital signs (heart rate, respiratory rate, and systolic blood pressure) among patients following the intervention. Additionally, there were no reported dog bites, scratches, or other adverse events during CAI.
CONCLUSIONS: CAI offers immediate therapeutic benefits in reducing anxiety symptoms in ICU patients and their family members with no observed adverse effects. It may also have a potential role as an adjunctive therapy for pain management in ICU patients. Further research should explore the influence on longer-term psychologic outcomes for ICU patients and family members.
参考来源
- Cook K, Robertson C, Gudivada K, et al. Pawsitive Care: Canine-Assisted Intervention for Anxiety in ICU Patients and Family Members: A Single-Center, Single-Arm Study. Crit Care Explor. 2025. PMID: 40293835. doi:10.1097/CCE.0000000000001258
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。